New

ADHD Therapeutics Market

2021

ADHD Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Stimulants, Non-Stimulants); Age Group (Pediatric, Adolescent, Adults); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce) and Geography

| Report Code: TIPRE00003833 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

ADHD Therapeutics Market 2028 By Drug Type, Age Group, Distribution Channel and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



ADHD (Attention Deficit/Hyperactivity Disorder) is a psychiatric disorder that most commonly affects children and adolescents. Due to unknown genetic causes and a lack of accurate biomarkers, diagnosing ADHD is difficult. Psychostimulants are the most commonly prescribed medications for ADHD because they help to reduce or prevent hyperactivity, inattention, and impulsive symptoms, thus improving quality of life. The key driving factors for the ADHD therapeutics market growth are, higher prevalence of ADHD and growing awareness regarding ADHD.

MARKET SCOPE



The "Global ADHD Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the ADHD therapeutics market with detailed market segmentation by drug type, age group and distribution channel. The report provides key statistics on the market status of the leading ADHD therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on drug type the market is segmented as, stimulants and non-stimulants.
  • Based on age group the market is segmented as, pediatric, adolescent and adults.
  • On the basis of distribution channel, the ADHD therapeutics market is segmented into hospital pharmacies, retail pharmacies and e-Commerce.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of ADHD in children is the key market driver for the ADHD therapeutics market.
  • Rising awareness about ADHD among people is also expected to spur the market growth during the forecast period.
  • Increase in number of product approvals, clinical trials and new product launches are expected to create significant growth opportunities for market.

Restraints:



  • However, presence of comorbidities in children along with delayed diagnosis of ADHD are likely to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The ADHD therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the ADHD therapeutics market in these regions.

IMPACT OF COVID-19 ON ADHD THERAPEUTICS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the ADHD therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from ADHD therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for ADHD therapeutics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the ADHD therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Lilly
  • Novartis AG
  • Pfizer, Inc.
  • Arbor Pharmaceuticals, LLC.
  • Noven Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Johnson and Johnson Services, Inc.
  • Corium Inc
  • Adlon Therapeutics L.P
  • Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 ADHD Therapeutics Market - By Drug Type
1.3.2 ADHD Therapeutics Market - By Age Group
1.3.3 ADHD Therapeutics Market - By Distribution Channel
1.3.4 ADHD Therapeutics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ADHD THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. ADHD THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ADHD THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ADHD THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ADHD THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. STIMULANTS
7.3.1. Overview
7.3.2. Stimulants Market Forecast and Analysis
7.3.3. Amphetamine Market
7.3.3.1. Overview
7.3.3.2. Amphetamine Market Forecast and Analysis
7.3.4. Methylphenidate Market
7.3.4.1. Overview
7.3.4.2. Methylphenidate Market Forecast and Analysis
7.3.5. Dextroamphetamine Market
7.3.5.1. Overview
7.3.5.2. Dextroamphetamine Market Forecast and Analysis
7.3.6. Dexmethylphenidate Market
7.3.6.1. Overview
7.3.6.2. Dexmethylphenidate Market Forecast and Analysis
7.3.7. Lisdexamfetamine Dimesylate Market
7.3.7.1. Overview
7.3.7.2. Lisdexamfetamine Dimesylate Market Forecast and Analysis
7.4. NON-STIMULANTS
7.4.1. Overview
7.4.2. Non-Stimulants Market Forecast and Analysis
7.4.3. Atomoxetine Market
7.4.3.1. Overview
7.4.3.2. Atomoxetine Market Forecast and Analysis
7.4.4. Bupropion Market
7.4.4.1. Overview
7.4.4.2. Bupropion Market Forecast and Analysis
7.4.5. Guanfacine Market
7.4.5.1. Overview
7.4.5.2. Guanfacine Market Forecast and Analysis
7.4.6. Clonidine Market
7.4.6.1. Overview
7.4.6.2. Clonidine Market Forecast and Analysis
8. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - AGE GROUP
8.1. OVERVIEW
8.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADOLESCENT
8.4.1. Overview
8.4.2. Adolescent Market Forecast and Analysis
8.5. ADULTS
8.5.1. Overview
8.5.2. Adults Market Forecast and Analysis
9. ADHD THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. e-Commerce Market Forecast and Analysis

10. ADHD THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America ADHD Therapeutics Market Overview
10.1.2 North America ADHD Therapeutics Market Forecasts and Analysis
10.1.3 North America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.1.5 North America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States ADHD Therapeutics Market
10.1.6.1.1 United States ADHD Therapeutics Market by Drug Type
10.1.6.1.2 United States ADHD Therapeutics Market by Age Group
10.1.6.1.3 United States ADHD Therapeutics Market by Distribution Channel
10.1.6.2 Canada ADHD Therapeutics Market
10.1.6.2.1 Canada ADHD Therapeutics Market by Drug Type
10.1.6.2.2 Canada ADHD Therapeutics Market by Age Group
10.1.6.2.3 Canada ADHD Therapeutics Market by Distribution Channel
10.1.6.3 Mexico ADHD Therapeutics Market
10.1.6.3.1 Mexico ADHD Therapeutics Market by Drug Type
10.1.6.3.2 Mexico ADHD Therapeutics Market by Age Group
10.1.6.3.3 Mexico ADHD Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe ADHD Therapeutics Market Overview
10.2.2 Europe ADHD Therapeutics Market Forecasts and Analysis
10.2.3 Europe ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.2.5 Europe ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany ADHD Therapeutics Market
10.2.6.1.1 Germany ADHD Therapeutics Market by Drug Type
10.2.6.1.2 Germany ADHD Therapeutics Market by Age Group
10.2.6.1.3 Germany ADHD Therapeutics Market by Distribution Channel
10.2.6.2 France ADHD Therapeutics Market
10.2.6.2.1 France ADHD Therapeutics Market by Drug Type
10.2.6.2.2 France ADHD Therapeutics Market by Age Group
10.2.6.2.3 France ADHD Therapeutics Market by Distribution Channel
10.2.6.3 Italy ADHD Therapeutics Market
10.2.6.3.1 Italy ADHD Therapeutics Market by Drug Type
10.2.6.3.2 Italy ADHD Therapeutics Market by Age Group
10.2.6.3.3 Italy ADHD Therapeutics Market by Distribution Channel
10.2.6.4 Spain ADHD Therapeutics Market
10.2.6.4.1 Spain ADHD Therapeutics Market by Drug Type
10.2.6.4.2 Spain ADHD Therapeutics Market by Age Group
10.2.6.4.3 Spain ADHD Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom ADHD Therapeutics Market
10.2.6.5.1 United Kingdom ADHD Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom ADHD Therapeutics Market by Age Group
10.2.6.5.3 United Kingdom ADHD Therapeutics Market by Distribution Channel
10.2.6.6 Rest of Europe ADHD Therapeutics Market
10.2.6.6.1 Rest of Europe ADHD Therapeutics Market by Drug Type
10.2.6.6.2 Rest of Europe ADHD Therapeutics Market by Age Group
10.2.6.6.3 Rest of Europe ADHD Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific ADHD Therapeutics Market Overview
10.3.2 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.3.5 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia ADHD Therapeutics Market
10.3.6.1.1 Australia ADHD Therapeutics Market by Drug Type
10.3.6.1.2 Australia ADHD Therapeutics Market by Age Group
10.3.6.1.3 Australia ADHD Therapeutics Market by Distribution Channel
10.3.6.2 China ADHD Therapeutics Market
10.3.6.2.1 China ADHD Therapeutics Market by Drug Type
10.3.6.2.2 China ADHD Therapeutics Market by Age Group
10.3.6.2.3 China ADHD Therapeutics Market by Distribution Channel
10.3.6.3 India ADHD Therapeutics Market
10.3.6.3.1 India ADHD Therapeutics Market by Drug Type
10.3.6.3.2 India ADHD Therapeutics Market by Age Group
10.3.6.3.3 India ADHD Therapeutics Market by Distribution Channel
10.3.6.4 Japan ADHD Therapeutics Market
10.3.6.4.1 Japan ADHD Therapeutics Market by Drug Type
10.3.6.4.2 Japan ADHD Therapeutics Market by Age Group
10.3.6.4.3 Japan ADHD Therapeutics Market by Distribution Channel
10.3.6.5 South Korea ADHD Therapeutics Market
10.3.6.5.1 South Korea ADHD Therapeutics Market by Drug Type
10.3.6.5.2 South Korea ADHD Therapeutics Market by Age Group
10.3.6.5.3 South Korea ADHD Therapeutics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific ADHD Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific ADHD Therapeutics Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific ADHD Therapeutics Market by Age Group
10.3.6.6.3 Rest of Asia-Pacific ADHD Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa ADHD Therapeutics Market Overview
10.4.2 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.4.5 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa ADHD Therapeutics Market
10.4.6.1.1 South Africa ADHD Therapeutics Market by Drug Type
10.4.6.1.2 South Africa ADHD Therapeutics Market by Age Group
10.4.6.1.3 South Africa ADHD Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia ADHD Therapeutics Market
10.4.6.2.1 Saudi Arabia ADHD Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia ADHD Therapeutics Market by Age Group
10.4.6.2.3 Saudi Arabia ADHD Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E ADHD Therapeutics Market
10.4.6.3.1 U.A.E ADHD Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E ADHD Therapeutics Market by Age Group
10.4.6.3.3 U.A.E ADHD Therapeutics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa ADHD Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa ADHD Therapeutics Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa ADHD Therapeutics Market by Age Group
10.4.6.4.3 Rest of Middle East and Africa ADHD Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America ADHD Therapeutics Market Overview
10.5.2 South and Central America ADHD Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Age Group
10.5.5 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America ADHD Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil ADHD Therapeutics Market
10.5.6.1.1 Brazil ADHD Therapeutics Market by Drug Type
10.5.6.1.2 Brazil ADHD Therapeutics Market by Age Group
10.5.6.1.3 Brazil ADHD Therapeutics Market by Distribution Channel
10.5.6.2 Argentina ADHD Therapeutics Market
10.5.6.2.1 Argentina ADHD Therapeutics Market by Drug Type
10.5.6.2.2 Argentina ADHD Therapeutics Market by Age Group
10.5.6.2.3 Argentina ADHD Therapeutics Market by Distribution Channel
10.5.6.3 Rest of South and Central America ADHD Therapeutics Market
10.5.6.3.1 Rest of South and Central America ADHD Therapeutics Market by Drug Type
10.5.6.3.2 Rest of South and Central America ADHD Therapeutics Market by Age Group
10.5.6.3.3 Rest of South and Central America ADHD Therapeutics Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ADHD THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. LILLY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ARBOR PHARMACEUTICALS, LLC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVEN PHARMACEUTICALS, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON SERVICES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CORIUM INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ADLON THERAPEUTICS L.P
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
"
The List of Companies

1. Lilly
2. Novartis AG
3. Pfizer, Inc.
4. Arbor Pharmaceuticals, LLC.
5. Noven Pharmaceuticals, Inc.
6. Takeda Pharmaceutical Company Limited
7. Johnson and Johnson Services, Inc.
8. Corium Inc
9. Adlon Therapeutics L.P
10. Teva Pharmaceutical Industries Ltd
TIPRE00003833
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.